Researchers identify distinct subtypes of polycystic ovary syndrome with novel genetic associations

June 23, 2020

Mount Sinai researchers have for the first time identified reproductive and metabolic subtypes of polycystic ovary syndrome (PCOS) that are associated with novel gene regions. The findings, which used clustering of clinical, metabolic, and hormonal data from women with the syndrome, promise to transform understanding of the cause of PCOS and, accordingly, will have far-reaching implications for its diagnosis and treatment. The results were published in PLOS Medicine on Tuesday, June 23.

PCOS is among the most common endocrine conditions in reproductive-age women, affecting up to 15 percent of this population worldwide. It is a leading cause of infertility and type 2 diabetes in young women. The cause of PCOS is unknown, but there is a strong inherited susceptibility to the disorder. It is currently diagnosed using different sets of clinical criteria based on expert opinion. There is considerable controversy about which criteria are the most appropriate.

"We're starting to make headway on what causes PCOS. It's very frustrating for patients because it's poorly understood and patients often see several physicians before PCOS is diagnosed," said senior author Andrea Dunaif, MD, Chief of the Hilda and J. Lester Gabrilove Division of Endocrinology, Diabetes and Bone Disease at the Mount Sinai Health System. "Through genetics, we're beginning to understand the condition and may have specific targeted therapies in the not-too-distant future."

Using clinical, biochemical, and genotype data from their previously published PCOS genome-wide association study (GWAS), Dr. Dunaif and her team identified the subtypes using cluster analysis, a way of aggregating similar data in an unbiased manner. Unsupervised cluster analysis, meaning there are no predetermined models of data, was performed in the GWAS cohort of 893 PCOS cases. The clusters were then replicated in an independent group of 263 PCOS cases.

The clustering revealed two distinct PCOS subtypes: a "reproductive" group characterized by higher luteinizing hormone (LH), a hormone that triggers ovulation and acts on the ovaries, and higher levels of sex hormone binding globulin (SHBG), a protein that regulates the ability of testosterone to enter its target tissues, with relatively low body mass index (BMI) and insulin levels; and a "metabolic" group characterized by higher BMI, glucose, and insulin levels with lower SHBG and LH levels.

This current paper builds upon a study that Dr. Dunaif and her team published in The Journal of Endocrinology and Metabolism in April 2019 where they found, using family-based genetic analysis, that rare genetic variants in a gene involved in male hormone production, DENND1A, play major roles in the development of PCOS. This genetic variation could serve as a marker for early PCOS detection.

In the study published today, the researchers developed a predictive model and classified the reproductive and metabolic subtypes in a family-based cohort of 73 women with PCOS, including their sisters. They found that the subtypes tended to cluster in families. They also found that carriers of the previously reported rare variants in DENND1A were more likely to have the reproductive subtype of PCOS. The results suggest that these subtypes are biologically relevant since they have distinct genetic architectures. The findings will substantially assist in gene discovery by allowing the selection of more homogeneous PCOS subtypes, which could increase the likelihood of identifying disease-associated genes.

"In contrast to classifying disorders based on expert opinion, this is a very powerful objective approach to categorizing syndromes like PCOS into distinct subtypes with different causes, treatment and clinical outcomes," said Dr. Dunaif.
-end-
The study was supported by grants from the National Institutes of Health.

About the Mount Sinai Health System

The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai is a national and international source of unrivaled education, translational research and discovery, and collaborative clinical leadership ensuring that we deliver the highest quality care--from prevention to treatment of the most serious and complex human diseases. The Health System includes more than 7,200 physicians and features a robust and continually expanding network of multispecialty services, including more than 400 ambulatory practice locations throughout the five boroughs of New York City, Westchester, and Long Island. The Mount Sinai Hospital is ranked No. 14 on U.S. News & World Report's "Honor Roll" of the Top 20 Best Hospitals in the country and the Icahn School of Medicine as one of the Top 20 Best Medical Schools in the country. Mount Sinai Health System hospitals are consistently ranked regionally by specialty by U.S. News & World Report.

For more information, visit https://www.mountsinai.org or find Mount Sinai on Facebook, Twitter and YouTube.

The Mount Sinai Hospital / Mount Sinai School of Medicine

Related Polycystic Ovary Syndrome Articles from Brightsurf:

Reproducing the pathophysiology of polycystic kidney disease from human iPS cells
A joint research project has successfully reproduced the pathogenesis of autosomal dominant polycystic kidney disease (ADPKD) from human iPS cells in vitro.

Young women with polycystic ovary syndrome have raised risk of heart disease
Women in their 30s and 40s with a common condition affecting how the ovaries work are more likely to get heart disease.

Scientists prove bird ovary tissue can be preserved in fossils
A research team led by Dr. Alida Bailleul from the Institute of Vertebrate Paleontology and Paleoanthropology (IVPP) of the Chinese Academy of Sciences has proved that remnants of bird ovaries can be preserved in the fossil record.

Genetic analysis suggests distinct subtypes of polycystic ovary syndrome
Polycystic ovary syndrome (PCOS), an infertility disorder affecting at least 15% of reproductive-age women, may have at least two different subtypes, suggests a study funded by the National Institutes of Health.

Researchers identify distinct subtypes of polycystic ovary syndrome with novel genetic associations
Findings could transform understanding of the syndrome's cause and have far-reaching implications for diagnosis and treatment.

Researchers develop new drugs for treating polycystic hepatorena
These new drugs are capable of blocking the growth of hepatic and renal cysts in experimental models of polycystic hepatorenal disease.

Mindful yoga reduces testosterone by 29% in women with polycystic ovary syndrome
New research shows the regular practice of mindful yoga helps ease symptoms and improve androgen levels in women with PCOS.

Study: How to safely remove ovary in girls for best results in fertility preservation
Using an experimental piglet model, researchers defined the safest laparoscopic technique for removing the ovary in young girls that also results in the best quality ovarian tissue for fertility preservation.

Step toward 'ink' development for 3-D printing a bioprosthetic ovary
For the first time, scientists identified and mapped the location of structural proteins in a pig ovary.

Women with polycystic ovary syndrome face higher risk of breathing difficulties
Women with polycystic ovary syndrome (PCOS) are more likely to develop poor respiratory health based on lung function tests, according to research presented at the European Respiratory Society International Congress.

Read More: Polycystic Ovary Syndrome News and Polycystic Ovary Syndrome Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.